NVNO
enVVeno Medical CorpNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$7.02M
P/E Ratio
—
EPS
$-33.06
Beta
1.09
52W High
$196.70
52W Low
$8.67
50-Day MA
$11.16
200-Day MA
$36.94
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About enVVeno Medical Corp
enVVeno Medical Corp is an innovative medical device company dedicated to transforming vascular access solutions for dialysis patients through its proprietary biocompatible technology. By addressing critical unmet needs in the dialysis sector, enVVeno enhances the safety and efficacy of vascular procedures, allowing it to capitalize on the growing vascular interventions market. The company's commitment to advanced engineering, coupled with stringent regulatory compliance, aligns it with the evolving healthcare landscape and reinforces its mission to improve patient outcomes in a vital area of medical care.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-20.76M |
| Operating Margin | 0.00% |
| Return on Equity | -56.20% |
| Return on Assets | -35.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $41.36 |
| Price-to-Book | 0.26 |
| Price-to-Sales (TTM) | 216.91 |
| EV/Revenue | 274.86 |
| EV/EBITDA | -0.87 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 655,520 |
| Float | 473,920 |
| % Insiders | 13.65% |
| % Institutions | 31.52% |
Historical Volatility
HV 10-Day
88.08%
HV 20-Day
66.96%
HV 30-Day
69.60%
HV 60-Day
88.13%
HV Rank
—
Volatility is currently expanding
Data last updated: 5/1/2026